Cynata Therapeutics Limited (CYYNF)

Cynata Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	10.51	6.21	16.17	23.8	26.72	13.65
Cash & Short-Term Investments	10.51	6.21	16.17	23.8	26.72	13.65
Cash Growth	-5.90%	-61.62%	-32.06%	-10.92%	95.73%	95.63%
Other Receivables	0.18	0.11	0.34	0.07	0.04	0.01
Receivables	0.18	0.11	0.34	0.07	0.25	0.01
Prepaid Expenses	0.18	0.22	0.33	0.24	0.29	0.18
Other Current Assets	0	0	0.03	0.03	0.03	0
Total Current Assets	10.86	6.54	16.86	24.14	27.28	13.85
Long-Term Deferred Charges	2	1.85	2.13	2.41	2.69	2.97
Total Assets	12.86	8.39	18.99	26.55	29.97	17.48
Accounts Payable	1.14	0.43	1.31	1.58	0.68	0.3
Accrued Expenses	0.23	0.74	0.95	1.01	0.93	0.39
Total Current Liabilities	1.37	1.17	2.26	2.59	1.6	0.69
Total Liabilities	1.37	1.17	2.26	2.59	1.6	0.69
Common Stock	89.39	81.62	81.62	74.9	74.9	57.17
Retained Earnings	-85.97	-82.32	-72.57	-58.3	-52.85	-45.16
Comprehensive Income & Other	8.06	7.91	7.68	7.36	6.32	4.79
Shareholders' Equity	11.49	7.22	16.73	23.96	28.37	16.79
Total Liabilities & Equity	12.86	8.39	18.99	26.55	29.97	17.48
Net Cash (Debt)	10.51	6.21	16.17	23.8	26.72	13.65
Net Cash Growth	-5.90%	-61.62%	-32.06%	-10.92%	95.73%	95.63%
Net Cash Per Share	0.06	0.03	0.11	0.17	0.20	0.13
Filing Date Shares Outstanding	225.25	180.55	179.63	143.28	143.28	117.12
Total Common Shares Outstanding	225.25	179.63	179.63	143.28	143.28	117.12
Working Capital	9.49	5.37	14.6	21.55	25.68	13.16
Book Value Per Share	0.05	0.04	0.09	0.17	0.20	0.14
Tangible Book Value	11.49	7.22	16.73	23.96	28.37	16.79
Tangible Book Value Per Share	0.05	0.04	0.09	0.17	0.20	0.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.